Physician profile
Michael J Camp
NPI 1558363622
$6,628.05
in general payments reported to CMS, 2019-2025
38 companies · $812 in 2025
The $812 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $426 · 2021: $776 · 2022: $1,414 · 2023: $1,203 · 2024: $834 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,848.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,531.21 | 2019-2025 | Jot Dx, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $752.62 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Cds - Mct/Cem Monitoring |
| Bard Peripheral Vascular, INC. | $673.92 | 2019-2025 | Fluency Endovascular Stent Graft, Crosser Iq |
| Novartis Pharmaceuticals Corporation | $564.85 | 2019-2025 | |
| Shockwave Medical, INC | $561.83 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $340.77 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $232.19 | 2022-2025 | Verquvo |
| Pfizer INC. | $209.65 | 2019-2025 | |
| Cordis US Corp. | $193.07 | 2022-2025 | Mynx Venous Vcd, Mynx Control Venous |
| Amgen INC. | $187.07 | 2019-2023 | Repatha |
| Philips North America LLC | $147.53 | 2019-2025 | Ecc Solutions, (792) Multi Modality Ivus Other Systems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.02 | 2021-2025 | Lifevest |
| Avinger INC. | $129.43 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $100.16 | 2020-2025 | Eliquis, Camzyos |
| Astellas Pharma US INC | $93.65 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $91.72 | 2019-2025 | Farxiga, Lokelma |
| Asahi Intecc USA, INC. | $85.66 | 2022-2025 | Peripheral Vascular, Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Janssen Pharmaceuticals, INC | $65.83 | 2022 | |
| Novo Nordisk INC | $60.84 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Regeneron Healthcare Solutions, INC. | $46.48 | 2019-2024 | Evkeeza |
| Baxter Healthcare | $42.25 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $41.12 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $37.39 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.13 | 2019 | |
| Gilead Sciences, INC. | $25.04 | 2019 | |
| Cvrx, INC. | $24.81 | 2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $24.04 | 2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $23.47 | 2019 | |
| Medtronic, INC. | $22.21 | 2025 | Symplicity G3 |
| W. L. Gore & Associates, INC. | $20.43 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Scpharmaceuticals INC. | $19.81 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.45 | 2022 | |
| Elutia, INC. | $17.10 | 2020 | |
| Ekos Corporation | $16.96 | 2019 | |
| Terumo Medical Corporation | $16.54 | 2020 | |
| Lantheus Medical Imaging, INC. | $16.13 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Camp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.